FXYD5 and carcinoma: Finally, we visualized and compared the stemness genes with higher expression in C0 FXYD5+ TCs and C1 APCDD1+ TCs using box line plots, and the results further validated the previous results, showing a stronger proliferative capacity in C0 FXYD5+ TCs and C1 APCDD1+ TCs as well as adenoma and carcinoma (Figures 3F–I).